These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32433753)

  • 1. Single-dose pharmacokinetics of temocillin in plasma and soft tissues of healthy volunteers after intravenous and subcutaneous administration: a randomized crossover microdialysis trial.
    Matzneller P; Ngougni Pokem P; Capron A; Lackner E; Wulkersdorfer B; Nussbaumer-Pröll A; Österreicher Z; Duchek M; Van de Velde S; Wallemacq PE; Mouton JW; Van Bambeke F; Zeitlinger M
    J Antimicrob Chemother; 2020 Sep; 75(9):2650-2656. PubMed ID: 32433753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue pharmacokinetics of telavancin in healthy volunteers: a microdialysis study.
    Matzneller P; Österreicher Z; Reiter B; Lackner E; Stimpfl T; Zeitlinger M
    J Antimicrob Chemother; 2016 Nov; 71(11):3179-3184. PubMed ID: 27494910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and soft tissue pharmacokinetics of ceftolozane/tazobactam in healthy volunteers after single and multiple intravenous infusion: a microdialysis study.
    Al Jalali V; Wölfl-Duchek M; Taubert M; Matzneller P; Lackner E; Dorn C; Kratzer A; Wulkersdorfer B; Österreicher Z; Zeitlinger M
    J Antimicrob Chemother; 2021 Aug; 76(9):2342-2351. PubMed ID: 34050650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline Fosamil.
    Matzneller P; Lackner E; Lagler H; Wulkersdorfer B; Österreicher Z; Zeitlinger M
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3617-25. PubMed ID: 27044549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Pharmacodynamics of Temocillin.
    Alexandre K; Fantin B
    Clin Pharmacokinet; 2018 Mar; 57(3):287-296. PubMed ID: 28849402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
    Burkhardt O; Brunner M; Schmidt S; Grant M; Tang Y; Derendorf H
    J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulations.
    Miranda Bastos AC; Vandecasteele SJ; Spinewine A; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2018 Jun; 73(6):1630-1638. PubMed ID: 29579214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temocillin pharmacokinetics in normal and impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1985; 29 Suppl 5():135-9. PubMed ID: 4029017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of temocillin after intravenous and intramuscular administration.
    Modr Z; Morávek J; Dvorácek K; Sechser T; Janků I; Krebs V
    Czech Med; 1986; 9(4):181-6. PubMed ID: 3102181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis.
    Müller M; Rohde B; Kovar A; Georgopoulos A; Eichler HG; Derendorf H
    J Clin Pharmacol; 1997 Dec; 37(12):1108-13. PubMed ID: 9506005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.
    Ullah S; Matzneller P; Zeitlinger M; Fuhr U; Taubert M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1097-1106. PubMed ID: 31062064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers.
    Burian B; Zeitlinger M; Donath O; Reznicek G; Sauermann R
    Antimicrob Agents Chemother; 2012 Jan; 56(1):532-5. PubMed ID: 22083466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid.
    Zeitlinger M; Schwameis R; Burian A; Burian B; Matzneller P; Müller M; Wicha WW; Strickmann DB; Prince W
    J Antimicrob Chemother; 2016 Apr; 71(4):1022-6. PubMed ID: 26747098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion.
    Ngougni Pokem P; Wittebole X; Collienne C; Rodriguez-Villalobos H; Tulkens PM; Elens L; Van Bambeke F; Laterre PF
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients.
    Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods.
    Zhang L; Wicha WW; Bhavnani SM; Rubino CM
    J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii27-iii34. PubMed ID: 30949708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.
    Oesterreicher Z; Eberl S; Wulkersdorfer B; Matzneller P; Eder C; van Duijn E; Vaes WHJ; Reiter B; Stimpfl T; Jäger W; Nussbaumer-Proell A; Marhofer D; Marhofer P; Langer O; Zeitlinger M
    Clin Pharmacokinet; 2022 May; 61(5):697-707. PubMed ID: 34997559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications.
    Ngougni Pokem P; Matzneller P; Vervaeke S; Wittebole X; Goeman L; Coessens M; Cottone E; Capron A; Wulkersdorfer B; Wallemacq P; Mouton JW; Muller AE; Zeitlinger M; Laterre PF; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2022 Sep; 77(10):2742-2753. PubMed ID: 36018077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.